GCP
IDYA icon

GSA Capital Partners’s IDEAYA Biosciences IDYA Stock Holding History

GSA Capital Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,641
Closed -$273K – 1926
2025
Q1 		$273K Sell
16,641
-272
-2% -$5.79K 0.02% 1216
2024
Q4 		$435K Buy
16,913
+1,850
+12% +$52.4K 0.03% 989
2024
Q3 		$477K Buy
+15,063
New +$571K 0.04% 935
2023
Q2 		– Sell
-16,621
Closed -$228K – 1697
2023
Q1 		$228K Buy
+16,621
New +$277K 0.02% 1187
2022
Q2 		– Sell
-54,215
Closed -$607K – 1582
2022
Q1 		$607K Buy
54,215
+39,952
+280% +$589K 0.08% 416
2021
Q4 		$337K Buy
+14,263
New +$331K 0.04% 854

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

GSA Capital Partners's IDYA Position: Q2 2025 in Review

GSA Capital Partners sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 16,641 shares — an estimated $273K sold.

GSA Capital Partners first reported a position in IDYA in Q4 2021 and held it in 6 quarters. The position peaked at $607K in Q1 2022. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • GSA Capital Partners reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 16,641 IDEAYA Biosciences shares in Q2 2025, an estimated $273K.
  • GSA Capital Partners first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 6 quarters.
  • GSA Capital Partners's IDEAYA Biosciences position peaked at $607K in Q1 2022.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.